0001104659-23-092542.txt : 20230816
0001104659-23-092542.hdr.sgml : 20230816
20230816160523
ACCESSION NUMBER: 0001104659-23-092542
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230814
FILED AS OF DATE: 20230816
DATE AS OF CHANGE: 20230816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carter Eric G
CENTRAL INDEX KEY: 0001387660
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40021
FILM NUMBER: 231178222
MAIL ADDRESS:
STREET 1: C/O KING PHARMACEUTICALS, INC.
STREET 2: 501 FIFTH STREET
CITY: BRISTOL
STATE: TN
ZIP: 37620
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AEON Biopharma, Inc.
CENTRAL INDEX KEY: 0001837607
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 853940478
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 PARK PLAZA
STREET 2: SUITE 1750
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: (949) 354-6499
MAIL ADDRESS:
STREET 1: 5 PARK PLAZA
STREET 2: SUITE 1750
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: Priveterra Acquisition Corp.
DATE OF NAME CHANGE: 20201222
4
1
tm2323956-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-08-14
0
0001837607
AEON Biopharma, Inc.
AEON
0001387660
Carter Eric G
5 PARK PLAZA, SUITE 1750
IRVINE
CA
92614
1
0
0
0
0
Stock Option
5.47
2023-08-14
4
A
0
58851
0
A
2033-08-13
Common Stock
58851
58851
D
Represents an award of stock options on August 14, 2023, which vests in three yearly installments from August 14, 2023, subject to the reporting person's continued service through the applicable vesting date.
/s/ Alexander Wilson, Attorney-in-Fact
2023-08-16